MPM BioVentures 2014, L.P. sold 259,837 Entrada Therapeutics shares at $7.11 to $7.41 per share between Sep. 4 and Sep. 9, 2026. The insider’s reported post-sale ownership was 3,885,115 shares, giving investors the disclosed sale size, price range and remaining stake.

Key Highlights

  • MPM BioVentures 2014, L.P. reported ownership of 3,885,115 shares after the transactions.
  • All sale entries carried transaction code S, denoting open-market sales in insider reporting.
  • MPM BioVentures 2018, L.P. also appears in the transaction description as an insider of Entrada Therapeutics.

Entrada Therapeutics, Inc. (NASDAQ: TRDA) saw MPM BioVentures 2014, L.P. sell 259,837 shares at prices ranging from $7.11 to $7.41 per share between Sep. 4 and Sep. 9, 2026. The activity covered separate sales recorded during that period.

Insider Ownership Stands

The reported sale total was divided across separate transactions rather than presented as one block. The price range applies to the shares sold, with individual transaction prices spanning $7.11 to $7.41 per share. The transaction description also names MPM BioVentures 2018, L.P. as an insider of Entrada Therapeutics.